Global Gene Therapy For Heart Failure Market Research Report 2022

SKU ID : QYR-21522096 | Publishing Date : 23-Aug-2022 | No. of pages : 86

Detailed TOC of Global Gene Therapy For Heart Failure Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapy For Heart Failure Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Gene Modification
        1.2.3 Gene Replacement
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Gene Therapy For Heart Failure Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Laboratory
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gene Therapy For Heart Failure Market Perspective (2017-2028)
    2.2 Gene Therapy For Heart Failure Growth Trends by Region
        2.2.1 Gene Therapy For Heart Failure Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gene Therapy For Heart Failure Historic Market Size by Region (2017-2022)
        2.2.3 Gene Therapy For Heart Failure Forecasted Market Size by Region (2023-2028)
    2.3 Gene Therapy For Heart Failure Market Dynamics
        2.3.1 Gene Therapy For Heart Failure Industry Trends
        2.3.2 Gene Therapy For Heart Failure Market Drivers
        2.3.3 Gene Therapy For Heart Failure Market Challenges
        2.3.4 Gene Therapy For Heart Failure Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapy For Heart Failure Players by Revenue
        3.1.1 Global Top Gene Therapy For Heart Failure Players by Revenue (2017-2022)
        3.1.2 Global Gene Therapy For Heart Failure Revenue Market Share by Players (2017-2022)
    3.2 Global Gene Therapy For Heart Failure Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapy For Heart Failure Revenue
    3.4 Global Gene Therapy For Heart Failure Market Concentration Ratio
        3.4.1 Global Gene Therapy For Heart Failure Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy For Heart Failure Revenue in 2021
    3.5 Gene Therapy For Heart Failure Key Players Head office and Area Served
    3.6 Key Players Gene Therapy For Heart Failure Product Solution and Service
    3.7 Date of Enter into Gene Therapy For Heart Failure Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy For Heart Failure Breakdown Data by Type
    4.1 Global Gene Therapy For Heart Failure Historic Market Size by Type (2017-2022)
    4.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2023-2028)
5 Gene Therapy For Heart Failure Breakdown Data by Application
    5.1 Global Gene Therapy For Heart Failure Historic Market Size by Application (2017-2022)
    5.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gene Therapy For Heart Failure Market Size (2017-2028)
    6.2 North America Gene Therapy For Heart Failure Market Size by Country (2017-2022)
    6.3 North America Gene Therapy For Heart Failure Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Gene Therapy For Heart Failure Market Size (2017-2028)
    7.2 Europe Gene Therapy For Heart Failure Market Size by Country (2017-2022)
    7.3 Europe Gene Therapy For Heart Failure Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy For Heart Failure Market Size (2017-2028)
    8.2 Asia-Pacific Gene Therapy For Heart Failure Market Size by Country (2017-2022)
    8.3 Asia-Pacific Gene Therapy For Heart Failure Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Gene Therapy For Heart Failure Market Size (2017-2028)
    9.2 Latin America Gene Therapy For Heart Failure Market Size by Country (2017-2022)
    9.3 Latin America Gene Therapy For Heart Failure Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy For Heart Failure Market Size (2017-2028)
    10.2 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2017-2022)
    10.3 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Askbio
        11.1.1 Askbio Company Detail
        11.1.2 Askbio Business Overview
        11.1.3 Askbio Gene Therapy For Heart Failure Introduction
        11.1.4 Askbio Revenue in Gene Therapy For Heart Failure Business (2017-2022)
        11.1.5 Askbio Recent Development
    11.2 RENOVACORINC
        11.2.1 RENOVACORINC Company Detail
        11.2.2 RENOVACORINC Business Overview
        11.2.3 RENOVACORINC Gene Therapy For Heart Failure Introduction
        11.2.4 RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2017-2022)
        11.2.5 RENOVACORINC Recent Development
    11.3 Uniqure
        11.3.1 Uniqure Company Detail
        11.3.2 Uniqure Business Overview
        11.3.3 Uniqure Gene Therapy For Heart Failure Introduction
        11.3.4 Uniqure Revenue in Gene Therapy For Heart Failure Business (2017-2022)
        11.3.5 Uniqure Recent Development
    11.4 DINAQOR
        11.4.1 DINAQOR Company Detail
        11.4.2 DINAQOR Business Overview
        11.4.3 DINAQOR Gene Therapy For Heart Failure Introduction
        11.4.4 DINAQOR Revenue in Gene Therapy For Heart Failure Business (2017-2022)
        11.4.5 DINAQOR Recent Development
    11.5 PRECIGEN
        11.5.1 PRECIGEN Company Detail
        11.5.2 PRECIGEN Business Overview
        11.5.3 PRECIGEN Gene Therapy For Heart Failure Introduction
        11.5.4 PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2017-2022)
        11.5.5 PRECIGEN Recent Development
    11.6 Heartseed
        11.6.1 Heartseed Company Detail
        11.6.2 Heartseed Business Overview
        11.6.3 Heartseed Gene Therapy For Heart Failure Introduction
        11.6.4 Heartseed Revenue in Gene Therapy For Heart Failure Business (2017-2022)
        11.6.5 Heartseed Recent Development
    11.7 Cardior
        11.7.1 Cardior Company Detail
        11.7.2 Cardior Business Overview
        11.7.3 Cardior Gene Therapy For Heart Failure Introduction
        11.7.4 Cardior Revenue in Gene Therapy For Heart Failure Business (2017-2022)
        11.7.5 Cardior Recent Development
    11.8 NOVARTIS
        11.8.1 NOVARTIS Company Detail
        11.8.2 NOVARTIS Business Overview
        11.8.3 NOVARTIS Gene Therapy For Heart Failure Introduction
        11.8.4 NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2017-2022)
        11.8.5 NOVARTIS Recent Development
    11.9 Blue Rock
        11.9.1 Blue Rock Company Detail
        11.9.2 Blue Rock Business Overview
        11.9.3 Blue Rock Gene Therapy For Heart Failure Introduction
        11.9.4 Blue Rock Revenue in Gene Therapy For Heart Failure Business (2017-2022)
        11.9.5 Blue Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Gene Therapy For Heart Failure Market Research Report 2022

List of Tables
    Table 1. Global Gene Therapy For Heart Failure Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Gene Modification
    Table 3. Key Players of Gene Replacement
    Table 4. Key Players of Others
    Table 5. Global Gene Therapy For Heart Failure Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Gene Therapy For Heart Failure Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Gene Therapy For Heart Failure Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Gene Therapy For Heart Failure Market Share by Region (2017-2022)
    Table 9. Global Gene Therapy For Heart Failure Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Gene Therapy For Heart Failure Market Share by Region (2023-2028)
    Table 11. Gene Therapy For Heart Failure Market Trends
    Table 12. Gene Therapy For Heart Failure Market Drivers
    Table 13. Gene Therapy For Heart Failure Market Challenges
    Table 14. Gene Therapy For Heart Failure Market Restraints
    Table 15. Global Gene Therapy For Heart Failure Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Gene Therapy For Heart Failure Market Share by Players (2017-2022)
    Table 17. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2021)
    Table 18. Ranking of Global Top Gene Therapy For Heart Failure Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Gene Therapy For Heart Failure Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Gene Therapy For Heart Failure Product Solution and Service
    Table 22. Date of Enter into Gene Therapy For Heart Failure Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Gene Therapy For Heart Failure Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2017-2022)
    Table 26. Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2023-2028)
    Table 28. Global Gene Therapy For Heart Failure Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2017-2022)
    Table 30. Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2023-2028)
    Table 32. North America Gene Therapy For Heart Failure Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Gene Therapy For Heart Failure Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Gene Therapy For Heart Failure Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Gene Therapy For Heart Failure Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Gene Therapy For Heart Failure Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Gene Therapy For Heart Failure Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Askbio Company Detail
    Table 43. Askbio Business Overview
    Table 44. Askbio Gene Therapy For Heart Failure Product
    Table 45. Askbio Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million)
    Table 46. Askbio Recent Development
    Table 47. RENOVACORINC Company Detail
    Table 48. RENOVACORINC Business Overview
    Table 49. RENOVACORINC Gene Therapy For Heart Failure Product
    Table 50. RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million)
    Table 51. RENOVACORINC Recent Development
    Table 52. Uniqure Company Detail
    Table 53. Uniqure Business Overview
    Table 54. Uniqure Gene Therapy For Heart Failure Product
    Table 55. Uniqure Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million)
    Table 56. Uniqure Recent Development
    Table 57. DINAQOR Company Detail
    Table 58. DINAQOR Business Overview
    Table 59. DINAQOR Gene Therapy For Heart Failure Product
    Table 60. DINAQOR Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million)
    Table 61. DINAQOR Recent Development
    Table 62. PRECIGEN Company Detail
    Table 63. PRECIGEN Business Overview
    Table 64. PRECIGEN Gene Therapy For Heart Failure Product
    Table 65. PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million)
    Table 66. PRECIGEN Recent Development
    Table 67. Heartseed Company Detail
    Table 68. Heartseed Business Overview
    Table 69. Heartseed Gene Therapy For Heart Failure Product
    Table 70. Heartseed Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million)
    Table 71. Heartseed Recent Development
    Table 72. Cardior Company Detail
    Table 73. Cardior Business Overview
    Table 74. Cardior Gene Therapy For Heart Failure Product
    Table 75. Cardior Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million)
    Table 76. Cardior Recent Development
    Table 77. NOVARTIS Company Detail
    Table 78. NOVARTIS Business Overview
    Table 79. NOVARTIS Gene Therapy For Heart Failure Product
    Table 80. NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million)
    Table 81. NOVARTIS Recent Development
    Table 82. Blue Rock Company Detail
    Table 83. Blue Rock Business Overview
    Table 84. Blue Rock Gene Therapy For Heart Failure Product
    Table 85. Blue Rock Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million)
    Table 86. Blue Rock Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy For Heart Failure Market Share by Type: 2021 VS 2028
    Figure 2. Gene Modification Features
    Figure 3. Gene Replacement Features
    Figure 4. Others Features
    Figure 5. Global Gene Therapy For Heart Failure Market Share by Application in 2021 & 2028
    Figure 6. Hospital Case Studies
    Figure 7. Laboratory Case Studies
    Figure 8. Others Case Studies
    Figure 9. Gene Therapy For Heart Failure Report Years Considered
    Figure 10. Global Gene Therapy For Heart Failure Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Gene Therapy For Heart Failure Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Gene Therapy For Heart Failure Market Share by Region: 2021 VS 2028
    Figure 13. Global Gene Therapy For Heart Failure Market Share by Players in 2021
    Figure 14. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy For Heart Failure Revenue in 2021
    Figure 16. North America Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Gene Therapy For Heart Failure Market Share by Country (2017-2028)
    Figure 18. United States Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Gene Therapy For Heart Failure Market Share by Country (2017-2028)
    Figure 22. Germany Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Gene Therapy For Heart Failure Market Share by Region (2017-2028)
    Figure 30. China Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Gene Therapy For Heart Failure Market Share by Country (2017-2028)
    Figure 38. Mexico Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Gene Therapy For Heart Failure Market Share by Country (2017-2028)
    Figure 42. Turkey Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Askbio Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022)
    Figure 45. RENOVACORINC Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022)
    Figure 46. Uniqure Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022)
    Figure 47. DINAQOR Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022)
    Figure 48. PRECIGEN Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022)
    Figure 49. Heartseed Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022)
    Figure 50. Cardior Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022)
    Figure 51. NOVARTIS Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022)
    Figure 52. Blue Rock Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed